Quantifying Radiation Effects of Iodinated Contrast Media in Pediatric CT Using DNA Damage Biomarkers
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27146145 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Otilia Nuta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, School of Sciences and Humanities, Nazarbayev University, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Contrast Media, Tomography, X-Ray Computed, DNA Damage, DNA Breaks, Double-Stranded. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This prospective single-center study investigated the impact of iodinated contrast agents (Ultravist/iopromide and Visipaque/iodixanol) on DNA double-strand breaks during pediatric chest computed tomography (CT). Twenty-six children underwent medically indicated chest CT between March 2022 and November 2024: unenhanced (n = 7), Ultravist-enhanced (n = 10), and Visipaque-enhanced (n = 9). Blood samples were collected before and 30 min post-CT. DNA damage was quantified by analyzing γ-H2AX and 53BP1 foci formation in peripheral lymphocytes using immunofluorescence microscopy. All groups showed significant increases in DNA damage following CT. The absolute increases were 0.915 ± 0.250 foci/cell (unenhanced), 0.972 ± 0.279 (Ultravist), and 1.261 ± 0.251 (Visipaque), representing 6.2% and 37.8% higher values in contrast groups. However, these differences between groups were not statistically significant (p = 0.579, Kruskal–Wallis test), with small effect sizes (Cohen’s d < 0.5 for all comparisons). Contrast-enhanced protocols employed higher radiation doses than unenhanced scans (CTDIvol: 4.04–4.57 mGy vs. 2.66 mGy). When DNA damage was normalized for CTDIvol, no significant differences were observed between groups (p = 0.659). DNA damage showed no significant correlation with dosimetric parameters. When accounting for radiation dose differences, iodinated contrast agents do not enhance radiation-induced DNA double-strand breaks in pediatric chest CT, confirming the safety of contrast-enhanced CT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, School of Sciences and Humanities, Nazarbayev University, Astana 010000, Kazakhstan.
- Department of Medicine, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
- Department of Physics 'Aldo Pontremoli' and INFN Milano, Università degli Studi di Milano, 20133 Milan, Italy.
- Clinical and Academic Department of Radiology and Nuclear Medicine, Heart Center, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
- Clinical and Academic Department of Radiology and Nuclear Medicine, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
ORCID-Profile: Antonio Sarno, Dinara Jumadilova
Zitieren
APA
Nuta, O., Kenessova, A., Sarno, A., Jumadilova, D., & Dautov, T. (2026). Quantifying Radiation Effects of Iodinated Contrast Media in Pediatric CT Using DNA Damage Biomarkers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146145
Vancouver
Nuta O, Kenessova A, Sarno A, Jumadilova D, Dautov T. Quantifying Radiation Effects of Iodinated Contrast Media in Pediatric CT Using DNA Damage Biomarkers. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146145
BibTeX
@article{Nuta2026,
author = {Nuta, Otilia and Kenessova, Ainur and Sarno, Antonio and Jumadilova, Dinara and Dautov, Tairkhan},
title = {Quantifying Radiation Effects of Iodinated Contrast Media in Pediatric CT Using DNA Damage Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27146145}
}
EUVIMED